drugset / Press release

Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients

2023-12-13 · Shattuck Labs, Inc. · original shattucklabs.com ↗

– Observed 79% Objective Response Rate (ORR) in frontline HR-MDS patients, primarily with TP53 mutations; initial complete response (CR)/marrow complete response (mCR) rate of 64% – – Observed 27% initial CR/complete response with incomplete hematologic recovery (CRi) in frontline TP53m AML patients, and 5/11 evaluable patients achieved stable disease with decreasing blast counts and peripheral blood count improvement, these patients continue on treatment – – SL-172154 demonstrated an acceptable safety and tolerability profile as a monotherapy and in combination with azacitidine (AZA) – – Shattuck to host conference call and webcast today, December 13, 2023 at 8:00 a.m. ET – AUSTIN, TX & DURHAM, NC, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced initial topline dose-expansion data from its ongoing Phase 1A/B clinical trial of SL-172154 in combination with AZA in frontline HR-MDS and TP53m AML patients. Initial data from the dose-expansion cohorts build on the complete dose-escalation data featured in a poster presentation on December 11, 2023 at the 65 th ASH Annual Meeting. “Both the frontline HR-MDS and TP53m AML expansion cohorts enrolled quickly after completion of the dose escalation study in the middle of this year, and we are pleased to share initial efficacy data, which begin to demonstrate the activity of SL-172154 beyond what is expected of AZA alone. In dose escalation, we saw a monotherapy response to SL-172154 in a heavily pre-treated relapsed/refractory (R/R) TP53m AML patient that allowed the patient to receive a stem cell transplant. That patient remains disease free.” said Dr. Lini Pandite, MBChB, M.B.A., Chief Medical Officer of Shattuck. “In frontline, the rate of complete responses in both the HR-MDS and TP53m AML cohorts is already encouraging, and when coupled with the observation of peripheral blood count recovery in most patients that have not yet achieved a complete response, and the fact that many of these patients are very early in their course of treatment and have not yet reached the median time at which a complete response is expected for azacitidine, suggests that the complete response rate may continue to improve in the coming months. As a result, we have amended both studies to increase the sample size and look forward to providing another update by mid-year 2024.” Phase 1B Trial of SL-172154 in Frontline TP53m AML and HR-MDS Key takeaways: Early efficacy observed for SL-172154 in combination with AZA in previously untreated HR-MDS and TP53m AML: HR-MDS : In 14 evaluable patients with previously untreated HR-MDS (13 of whom had TP53m or deletion), five patients achieved a CR. Four patients achieved a mCR (3 with hematologic improvement in at least one lineage), and two patients achieved stable disease (both with hematologic improvement in at least one lineage). TP53m AML : In 11 evaluable patients with previously untreated TP53m AML, two patients achieved a CR. Another patient achieved a CRi and was taken to allogeneic hematopoietic cell transplantation (allo-HCT). Seven additional subjects with stable disease had blast reductions, five of which had recovery of platelets or neutrophils and remain on study and their response may improve. One subject died during the first cycle. Safety : Preliminary data suggest that SL-172154 has an acceptable safety and tolerability profile in combination with azacitidine. Data Overview: As of the data cut-off date of December 1, 2023, 14 frontline patients enrolled in the TP53m AML cohort, and 22 frontline patients enrolled in the HR-MDS cohort. Initial enrollment was completed in the fourth quarter of 2023 and Shattuck has elected to expand the cohorts with additional data expected mid-year 2024. Preliminary signs of anti-tumor activity: Early signals of activity, in the form of rapid blast count reductions, were observed in 100% of frontline TP53m AML patients treated with SL-172154 in combination with AZA who received an on-treatment bone marrow biopsy. Most patients in the HR-MDS cohort showed blast count reductions with hematologic improvement early in the treatment course. SL-172154 had an acceptable safety and tolerability profile: Infusion-related reactions (IRRs) were the most common SL-172154 related treatment-emergent adverse events (TEAEs). In the TP53m AML and HR-MDS cohorts, IRRs were reported in seven patients (50%) and seven patients (32%) respectively. Grade 3 or 4 AEs related to SL-172154 were reported in two patients (14%) in TP53m AML and four patient (18%) in HR-MDS, including IRR (2), increased AST (1), increased ALT (1), fatigue (1), hypoxia (1), pneumonia (1), chondrocalcinosis (1), and febrile neutropenia (1). There were no reports of destructive anemia. In the TP35m AML expansion cohort, there was one Grade 5 AE of cardiac arrest reported in one patient with history of coronary artery disease, recent arrhythmia, and hypokalemia in the setting of amiodarone use. In the HR-MDS cohort, there were no Grade 5 AEs related to SL-172154 reported. Phase 1A Trial of SL-172154 in R/R AML and HR-MDS and Frontline TP53m HR-MDS A copy of the ASH presentation, titled “Safety, Pharmacodynamic, and Anti-Tumor Activity of SL-172154 as Monotherapy and in Combination with Azacitidine (AZA) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes/neoplasms (HR-MDS) Patients (pts),” is accessible under posters in the “Our Science” section of Shattuck’s website. Key takeaways: Anti-tumor responses were observed as monotherapy and in combination with AZA. SL-172154 alone and in combination with AZA had an acceptable safety profile, consistent with the safety profile of the individual agents (see SL-172154 safety above). No destructive anemia was observed. Data Overview : As of the data cut-off date of September 15, 2023, 32 adult patients with R/R AML and HR-MDS received SL-172154 as monotherapy or in combination with AZA in the parallel staggered dose-escalation portion of a Phase 1A/B clinical trial. Patients had a median of two prior lines of therapy. An additional five subjects with frontline TP53m HR-MDS received SL-172154 with AZA. Preliminary signs of anti-tumor activity : Monotherapy response in a R/R AML patient and early signals of anti-leukemic activity (in the form of blast count reductions) in patients with R/R AML who received SL-172154 in combination with AZA were observed in a dose-dependent manner. SL-172154 monotherapy activity (Morphologic Leukemia-Free State) was observed in a heavily pretreated R/R AML patient and subsequently proceeded to allo-HCT. Patient achieved MLFS (blast reduction from 19% to <5%) after one cycle of SL-172154. Anti-tumor activity was also observed in combination with AZA in previously untreated TP53m HR-MDS patients. Out of four evaluable previously untreated TP53m HR-MDS patients, there was one CR and one mCR. One patient with mCR and one patient with SD proceeded to allo-HCT. The patient in a CR remains in a CR long term. Conference Call at 8:00 a.m. ET Today Shattuck will host a conference call today at 8:00 a.m. ET featuring key opinion leader Dr. Naval Daver, MD, (Professor, Director Leukemia Research Alliance Program, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX) to present the initial data from the frontline expansion cohorts in HR-MDS and TP53m AML. Additionally, a review of data from the poster presentation featured at the 65 th ASH Annual Meeting will be discussed. To listen to the live webcast, please visit the Investor Relations page of the Shattuck Labs website here . Participants may register for the call here . While not required, interested participants are encouraged to join 10 minutes prior to the start of the event. A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company’s website. About SL-172154 SL-172154 (SIRPα-Fc-CD40L) is an investigational ARC® fusion protein designed to simultaneously inhibit the CD47/SIRPα checkpoint interaction and activate the CD40 costimulatory receptor to bolster an anti-tumor immune response in patients with advanced cancer. Multiple Phase 1 clinical trials are ongoing for patients with PROC (NCT04406623, NCT05483933) and patients with AML and HR-MDS (NCT05275439). About Shattuck Labs, Inc. Shattuck Labs, Inc. (NASDAQ: STTK) is a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Compounds derived from Shattuck’s proprietary Agonist Redirected Checkpoint, (“ARC®”), platform are designed to simultaneously inhibit checkpoint molecules and activate costimulatory molecules with a single therapeutic. The company’s lead SL-172154 (SIRPα-Fc-CD40L) program, which is designed to block the CD47 immune checkpoint and simultaneously agonize the CD40 pathway, is being evaluated in multiple Phase 1 trials. Shattuck has offices in both Austin, Texas and Durham, North Carolina. For more information, please visit: www.ShattuckLabs.com . Forward-Looking Statements Certain statements in this press release may constitute “forward-looking statements” within the meaning of the federal securities laws, including, but not limited to, the clinical benefit of SL-172154 in frontline HR-MDS and TP53m AML patients, the safety and tolerability profile of SL-172154, and the anticipated timing of additional data from our clinical trials. Words such as “may,” “might,” “will,” “objective,” “intend,” “should,” “could,” “can,” “would,” “expect,” “believe,” “design,” “estimate,” “predict,” “potential,” “develop,” “plan” or the negative of these terms, and similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While we believe these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties (including, without limitation, those set forth in our filings with the U.S. Securities and Exchange Commission (the “SEC”)), many of which are beyond our control and subject to change. Actual results could be materially different. Risks and uncertainties include: global macroeconomic conditions and related volatility, expectations regarding the initiation, progress, and expected results of our preclinical studies, clinical trials and research and development programs; expectations regarding the timing, completion and outcome of our clinical trials; the unpredictable relationship between preclinical study results and clinical study results; the timing or likelihood of regulatory filings and approvals; liquidity and capital resources; and other risks and uncertainties identified in our Annual Report on Form 10-K for the year ended December 31, 2022, and subsequent disclosure documents filed with the SEC. We claim the protection of the Safe Harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements. We expressly disclaim any obligation to update or alter any statements whether as a result of new information, future events or otherwise, except as required by law. The Company intends to use the investor relations portion of its website as a means of disclosing material non-public information and for complying with disclosure obligations under Regulation FD. Investor & Media Contact: Conor Richardson Vice President of Investor Relations Shattuck Labs, Inc. [email protected] Source: Shattuck Labs, Inc. View All News #_ctrl0_ctl07_divModuleContainer.evergreen-wysiwyg { background-color: var(--evgBrand1Color); } #_ctrl0_ctl07_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { --alignment: center; } #_ctrl0_ctl07_divModuleContainer .evergreen-item { --backgroundColor: var(--evgBrand1Color); } @media (min-width: 481px) and (max-width: 1024px) { #_ctrl0_ctl07_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { } } @media (max-width: 480px) { #_ctrl0_ctl07_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { } } #_ctrl0_ctl07_divModuleContainer .evergreen-card-c { --border:none; } #_ctrl0_ctl07_divModuleContainer .evergreen-card-c:hover { --border:none; } #_ctrl0_ctl07_divModuleContainer .evergreen-card-c:focus { --border:none; } #evergreen_grid_footer_pane_main.evergreen-grid .evergreen-grid-title { background-color: transparent; padding-top: 50px; padding-bottom: 0px; margin-bottom: -20px; } #evergreen_grid_footer_pane_main.evergreen-grid.evergreen-grid-wrapper { background-size: cover; background-position: center; background-repeat: no-repeat; position: relative; } #evergreen_grid_footer_pane_main.evergreen-grid.evergreen-grid-wrapper::after { position: absolute; content: ""; top: 0; left: 0; bottom: 0; right: 0; } #evergreen_grid_footer_pane_main.evergreen-grid .evergreen-grid-container { border-top: none ; border-bottom: none ; position: relative; z-index: 1; } #evergreen_grid_footer_pane_main.evergreen-grid .evergreen-grid-title, #evergreen_grid_footer_pane_main.evergreen-grid .evergreen-grid-module { z-index: 1; } #evergreen_grid_footer_pane_main.evergreen-grid { --evergreenGridModulePaddingLeft: 0; --evergreenGridModulePaddingRight: 0; } #evergreen_grid_footer_pane_main.evergreen-grid .evergreen-grid-module > .evergreen { padding-left: var(--evergreenGridModulePaddingLeft); padding-right: var(--evergreenGridModulePaddingRight); } #evergreen_grid_footer_pane_main.evergreen-grid .evergreen-grid.evergreen-grid-container { } @media (max-width: 480px){ #_ctrl0_FooterPane_footer_pane_main_ctl04_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { font-size: 20px; } #_ctrl0_FooterPane_footer_pane_main_ctl04_divModuleContainer .evergreen-item-title { font-size: 14px; } #_ctrl0_FooterPane_footer_pane_main_ctl04_divModuleContainer .evergreen-link { font-size: 14px; } } @media (min-width: 481px) and (max-width: 1024px){ #_ctrl0_FooterPane_footer_pane_main_ctl04_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { font-size: 20px; } #_ctrl0_FooterPane_footer_pane_main_ctl04_divModuleContainer .evergreen-item-title { font-size: 14px; } #_ctrl0_FooterPane_footer_pane_main_ctl04_divModuleContainer .evergreen-link { font-size: 14px; } } @media (min-width: 1025px) { #_ctrl0_FooterPane_footer_pane_main_ctl04_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { font-size: 20px; } #_ctrl0_FooterPane_footer_pane_main_ctl04_divModuleContainer .evergreen-item-title { font-size: 14px; } #_ctrl0_FooterPane_footer_pane_main_ctl04_divModuleContainer .evergreen-link { font-size: 14px; } } #_ctrl0_FooterPane_footer_pane_main_ctl04_divModuleContainer.evergreen { background: var(--evgBrand1Color); } #_ctrl0_FooterPane_footer_pane_main_ctl04_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { text-align: left; color: var(--evgLightColor); line-height: 1; } #_ctrl0_FooterPane_footer_pane_main_ctl04_divModuleContainer .evergreen-item { background: var(--evgBrand1Color); border-bottom: 0 none; } #_ctrl0_FooterPane_footer_pane_main_ctl04_divModuleContainer .evergreen-item-title { } #_ctrl0_FooterPane_footer_pane_main_ctl04_divModuleContainer .evergreen-link { font-weight: normal; line-height: 1; } #_ctrl0_FooterPane_footer_pane_main_ctl04_divModuleContainer .evergreen-link:not(:hover):not(:focus) { color: var(--evgLightColor); } #_ctrl0_FooterPane_footer_pane_main_ctl04_divModuleContainer .evergreen-link:hover { color: var(--evgLightColor); text-decoration: underline solid; text-decoration-color: var(--evgLightColor); } #_ctrl0_FooterPane_footer_pane_main_ctl04_divModuleContainer .evergreen-link:focus, .evergreen-link:focus-visible { color: var(--evgLightColor); text-decoration: underline solid; text-decoration-color: var(--evgLightColor); } About Management Team opens in new window Board of Directors opens in new window @media (max-width: 480px){ #_ctrl0_FooterPane_footer_pane_main_ctl07_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { font-size: 20px; } #_ctrl0_FooterPane_footer_pane_main_ctl07_divModuleContainer .evergreen-link { font-size: 14px; } } @media (min-width: 481px) and (max-width: 1024px){ #_ctrl0_FooterPane_footer_pane_main_ctl07_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { font-size: 20px; } #_ctrl0_FooterPane_footer_pane_main_ctl07_divModuleContainer .evergreen-link { font-size: 14px; } } @media (min-width: 1025px) { #_ctrl0_FooterPane_footer_pane_main_ctl07_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { font-size: 20px; } #_ctrl0_FooterPane_footer_pane_main_ctl07_divModuleContainer .evergreen-link { font-size: 14px; } } #_ctrl0_FooterPane_footer_pane_main_ctl07_divModuleContainer.evergreen { background: var(--evgBrand1Color); } #_ctrl0_FooterPane_footer_pane_main_ctl07_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { text-align: left; color: var(--evgLightColor); line-height: 1; } #_ctrl0_FooterPane_footer_pane_main_ctl07_divModuleContainer .evergreen-item { background: var(--evgBrand1Color); border-bottom: 0 none; } #_ctrl0_FooterPane_footer_pane_main_ctl07_divModuleContainer .evergreen-item-title { } #_ctrl0_FooterPane_footer_pane_main_ctl07_divModuleContainer .evergreen-link { } #_ctrl0_FooterPane_footer_pane_main_ctl07_divModuleContainer .evergreen-link:not(:hover):not(:focus) { color: var(--evgLightColor); text-decoration-color: var(--evgLightColor); } #_ctrl0_FooterPane_footer_pane_main_ctl07_divModuleContainer .evergreen-link:hover { color: var(--evgLightColor); text-decoration-color: var(--evgLightColor); } #_ctrl0_FooterPane_footer_pane_main_ctl07_divModuleContainer .evergreen-link:focus, .evergreen-link:focus-visible { color: var(--evgLightColor); text-decoration-color: var(--evgLightColor); } Our Science SL-325 opens in new window Publications opens in new window @media (max-width: 480px){ #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { font-size: 20px; } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-input { font-size: 12px; } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-checkbox label, #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-radio label { font-size: 14px; } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-link { font-size: 12px; } } @media (min-width: 481px) and (max-width: 1024px){ #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { font-size: 20px; } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-input { font-size: 12px; } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-checkbox label, #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-radio label { font-size: 14px; } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-link { font-size: 12px; } } @media (min-width: 1025px) { #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-header .evergreen-title .ModuleTitle { font-size: 20px; } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-checkbox label, #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-radio label { font-size: 14px; } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-link { font-size: 12px; } } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-header .evergreen-title .ModuleTitle { line-height: 1; --fontColor: var(--evgLightColor); --alignment: left; } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen { background: var(--evgBrand1Color); } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-accordion-content p { color: var(--evgLightColor); } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-item-container, #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-item-container ul, #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-item li { background: var(--evgBrand1Color); } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-item li, #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-item li:nth-child(even) { border-bottom: 1px none; } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-intro p, #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-mailing-list-message, #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-mailing-list-privacy-text { color: var(--evgLightColor) } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-label { line-height: 0; } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-input { line-height: 3; background: var(--evgLightColor); border-color: var(--evgLightColor); border-radius: 50; } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-input::placeholder { } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-input:focus { border-color: var(--evgLightColor); } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-checkbox label, #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-radio label { color: var(--evgLightColor); } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-checkbox input[type="checkbox"], #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-radio input[type="radio"] { --borderColor: var(--evgLightColor); --fillColor: var(--evgBrand1Color); } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-checkbox input[type="checkbox"]:checked, #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-radio input[type="radio"]:checked { --borderColor: var(--evgLightColor); --fillColor: var(--evgLightColor); } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-button, #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-button--alt { } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-button:hover, #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-button--alt:hover { } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-button:focus, #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-button--alt:focus { } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-link { color: var(--evgLightColor); } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-link:hover { color: var(--evgLightColor); } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-link:focus { color: var(--evgLightColor); } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-error { --fontColor: var(--evgLightColor); } #_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer.evergreen .evergreen-error--hidden { display: none; } Investor Email Alerts Email Address * Required Email Address is required. Email Address is invalid. Investor Alert Options * News Quarterly Reports Annual Reports SEC Filings End of Day Stock Quote Events & Presentations Investor Alert Options is required. function onLoad__ctrl0_FooterPane_footer_pane_main_ctl10_recaptcha() { grecaptcha.render('_ctrl0_FooterPane_footer_pane_main_ctl10_btnSubmit', { 'sitekey': '6LcKf8wZAAAAADYEeFvKUvdj80FVct5G98mSJ29W', 'callback': 'onSubmit__ctrl0_FooterPane_footer_pane_main_ctl10_recaptcha', 'size': 'invisible' }); // Prevent immediate postback: ASP.NET adds onclick (Page_ClientValidate + __doPostBack) to the button. // Only the reCAPTCHA callback should trigger postback, after the challenge is completed. var btn = document.getElementById('_ctrl0_FooterPane_footer_pane_main_ctl10_btnSubmit'); if (btn) btn.removeAttribute('onclick'); } function onSubmit__ctrl0_FooterPane_footer_pane_main_ctl10_recaptcha(token) { var captchaTokenField = document.getElementById('_ctrl0_FooterPane_footer_pane_main_ctl10_recaptcha_hdnCaptchaToken'); captchaTokenField.value = token; __doPostBack('_ctrl0$FooterPane_footer_pane_main$ctl10$btnSubmit', ""); } .grecaptcha-badge { display: none !important; } The captcha test has failed. Please try again. Submit Unsubscribe $tudio('#_ctrl0_FooterPane_footer_pane_main_ctl10_divModuleContainer').find("input[type='checkbox'], input[type='radio']").keypress(function (e) { e.preventDefault(); if (e.which == 13) { $(this).click(); } }); window.addEventListener("q4cc-onload", function () { $tudio(window).q4CookieConsent({ language: {"bannerTitle":"Cookies on this website","bannerDescription":"We use cookies on \u003ca href=\"https://www.shattucklabs.com/\"\u003eshattucklabs.com\u003c/a\u003e to provide you with the best possible experience. If you wish to review the cookies we store, please select the Cookie Preferences option on this banner. After your preferences are saved, you can use the cookie icon at the left to modify your selections at any time. For more information, you can review our \u003ca href=\"https://www.shattucklabs.com/privacy-policy/\"\u003ePrivacy Policy\u003c/a\u003e.","bannerPreferenceBtn":"Cookie Preferences","bannerAcceptBtn":"Accept All","bannerRejectBtn":"Reject All","preferenceTitle":"Customize your cookie preferences","preferenceDescription":"Your preferences can be changed at any time by clicking on “Cookie preferences” at the very bottom of the site. All changes will be saved automatically.","preferenceNecessaryTitle":"Necessary Cookies","preferenceNecessaryDescription":"Necessary cookies are required to make sure your experience on this website runs smoothly and cannot be opted out of.","preferenceNecessaryStatus":"Always Active","preferenceOptionalTitle":"Optional Cookies","preferenceOptionalDescription":"Optional cookies help us understand how you use this website to further optimize your browsing experience.","preferenceOptionalAcceptStatus":"All cookies accepted","preferenceOptionalRejectStatus":"All cookies rejected","preferenceOptionalSomeStatus":"Some cookies accepted","floatingPreferenceBtn":"Preferences","preferenceOptionalAcceptAllBtn":"Accept All","preferenceOptionalRejectAllBtn":"Reject All","preferenceOptionalToggleOn":"On","preferenceOptionalToggleOff":"Off","closeBtn":"Close"}}); }); Gap List Fixes /* .evergreen-layout-header-wrapper header.evergreen-layout-header { margin-top: 80px !important; } */ .evergreen-layout .evergreen-layout-header--small-banner .evergreen-layout-header-overlay { display: block; } .evergreen-layout .evergreen-layout-header--small-banner .evergreen-layout-header-overlay .evergreen-layout-header-overlay-color { background-color: #f3f3f3; z-index: -2; } .evergreen-event .evergreen-container .evergreen-event-layout-card.evergreen-event-layout-card--vertical .evergreen-event-content .evergreen-event-item { height: 445px; /*border: 1px solid var(--evgPrimaryColor);*/ } .evergreen-latest-quarter-layout--square { box-shadow: 1px 1px 16px 0px rgba(62, 70, 81, .08), 4px 4px 8px 0px rgba(62, 70, 81, .08), 2px 2px 4px -1px rgba(62, 70, 81, .08); /*border: 1px solid var(--evgPrimaryColor);*/ border-radius: 20px; } .evergreen-latest-quarter-layout--square .evergreen-latest-quarter-report-period { border-top-left-radius: 20px; border-bottom-left-radius: 20px; } .evergreen-latest-quarter-layout--square .evergreen-latest-quarter-report-documents { border-top-right-radius: 20px; border-bottom-right-radius: 20px; } #_ctrl0_FooterPane2-footer-pane-secondary_ctl04_divQuickLinkItemsContainer { margin-top: 3px; } #_ctrl0_FooterPane2-footer-pane-secondary_ctl07_divModuleContainer p { margin: -3px; } #_ctrl0_ctl17_divModuleContainer { padding: 10px 0px; } #_ctrl0_FooterPane-footer-pane-main_ctl10_divModuleContainer { padding: 50px 0 5px 0; } .evergreen-layout-header-wrapper { padding-bottom: var(--staticBannerHorizontalPadding) !important; } .PageOverview .evergreen-layout-header-wrapper { padding-bottom: 0 !important; } .ParentSection_stock-info .evergreen-layout-header-wrapper, .ParentSection_financials .evergreen-layout-header-wrapper, .ParentSection_governance .evergreen-layout-header-wrapper, .ParentSection_esg-1 .evergreen-layout-header-wrapper, .ParentSection_resources .evergreen-layout-header-wrapper, .PageStockInfo .evergreen-layout-header-wrapper { margin-bottom: 30px; } .evergreen select.evergreen-dropdown { min-width: 150px; } .evergreen .evergreen-dropdown-wrapper:before { right: 15px; } .StudioBase .evergreen.module-stock-chart .highcharts-button text { font-size: 0.8em !important; } .StudioBase .module-form_item>label { color: var(--evgPrimaryColor); } .ParentSection_esg-1 #_ctrl0_ctl20_divModuleContainer { padding-bottom: 0; } /* .ParentSection_esg-1 #_ctrl0_ctl23_divModuleContainer { padding-top: 0; }*/ .evergreen-financial-gallery .evergreen-container.evergreen-container-content.evergreen-financial-gallery-container--details .evergreen-financial-gallery-item-image-container img { width: auto !important; } .evergreen-financial--accordion .evergreen-financial-accordion-card-header { padding: 5px; padding-left: 15px; } .PageOverview .evergreen-news-content .evergreen-item--card:last-child { margin-bottom: 10px; } .evergreen-financial-gallery-item-image-container { text-align: center; } .evergreen-layout iframe, .evergreen-layout video { border-radius: 20px; } /* .evergreen-layout video { height: auto; } */ .evergreen-financial-gallery-item .evergreen-financial-gallery-item-links-container { margin-left: auto; margin-right: auto; width: fit-content; padding-right: 22px; } .evergreen-wysiwyg table, .evergreen-wysiwyg table td { vertical-align: top; } @media (max-width: 768px) { .evergreen-wysiwyg table td { display: block; } .evergreen-wysiwyg table colgroup col { width: 100% !important; } } .evergreen-financial-accordion-card.evergreen-financial-accordion-card--border { background: var(--evgGreyColor); } .evergreen-secondary-navigation .evergreen-secondary-navigation-container ul li>a.evergreen-navigation-link { padding-top: 0; } .evergreen-section--sticky .evergreen-secondary-navigation .evergreen-secondary-navigation-container ul li>a.evergreen-navigation-link { padding-top: 15px; } .evergreen-pane--sub-footer .evergreen-wysiwyg p { margin: 0 !important; } /* 01162687 */ .evergreen-primary-navigation .evergreen-primary-navigation-menu.evergreen-primary-navigation-menu--corporate .evergreen-primary-navigation-menu-content-wrapper { max-width: 1220px !important; } .evergreen-primary-navigation .evergreen-primary-navigation-menu-content-wrapper { max-width: 1260px !important; } .evergreen-grid .evergreen-grid.evergreen-grid-container { --evergreenGridModulePadding: 0 !important; --evergreenGridModuleMaxWidth: 1220px !important; } .evergreen-latest-quarter-report-documents { padding-inline: 0 !important; } .evergreen-latest-quarter-report-period { justify-content: flex-start; align-items: flex-start; } #evergreen_grid_event_1 .evergreen-event .evergreen-container .evergreen-event-layout-card .evergreen-event-item { --evgPaddingContainerPadding: 20px } /* 01162687 end */ #evergreen_grid_footer_pane_sec.evergreen-grid .evergreen-grid-title { background-color: transparent; padding-top: 50px; padding-bottom: 0px; margin-bottom: -20px; } #evergreen_grid_footer_pane_sec.evergreen-grid.evergreen-grid-wrapper { background-size: cover; background-position: center; background-repeat: no-repeat; position: relative; } #evergreen_grid_footer_pane_sec.evergreen-grid.evergreen-grid-wrapper::after { position: absolute; content: ""; top: 0; left: 0; bottom: 0; right: 0; } #evergreen_grid_footer_pane_sec.evergreen-grid .evergreen-grid-container { border-top: none ; border-bottom: none ; position: relative; z-index: 1; } #evergreen_grid_footer_pane_sec.evergreen-grid .evergreen-grid-title, #evergreen_grid_footer_pane_sec.evergreen-grid .evergreen-grid-module { z-index: 1; } #evergreen_grid_footer_pane_sec.evergreen-grid { --evergreenGridModulePaddingLeft: 0; --evergreenGridModulePaddingRight: 0; } #evergreen_grid_footer_pane_sec.evergreen-grid .evergreen-grid-module > .evergreen { padding-left: var(--evergreenGridModulePaddingLeft); padding-right: var(--evergreenGridModulePaddingRight); } #evergreen_grid_footer_pane_sec.evergreen-grid .evergreen-grid.evergreen-grid-container { } @media (max-width: 480px){ #_ctrl0_FooterPane_footer_pane_sec_ctl04_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { font-size: 20px; } #_ctrl0_FooterPane_footer_pane_sec_ctl04_divModuleContainer .evergreen-link { font-size: 14px; } } @media (min-width: 481px) and (max-width: 1024px){ #_ctrl0_FooterPane_footer_pane_sec_ctl04_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { font-size: 20px; } #_ctrl0_FooterPane_footer_pane_sec_ctl04_divModuleContainer .evergreen-link { font-size: 14px; } } @media (min-width: 1025px) { #_ctrl0_FooterPane_footer_pane_sec_ctl04_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { font-size: 20px; } #_ctrl0_FooterPane_footer_pane_sec_ctl04_divModuleContainer .evergreen-link { font-size: 14px; } } #_ctrl0_FooterPane_footer_pane_sec_ctl04_divModuleContainer.evergreen { background: var(--evgBrand1Color); } #_ctrl0_FooterPane_footer_pane_sec_ctl04_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { text-align: left; color: var(--evgLightColor); line-height: 1; } #_ctrl0_FooterPane_footer_pane_sec_ctl04_divModuleContainer .evergreen-item { background: var(--evgBrand1Color); border-bottom: 0 none; } #_ctrl0_FooterPane_footer_pane_sec_ctl04_divModuleContainer .evergreen-item-title { } #_ctrl0_FooterPane_footer_pane_sec_ctl04_divModuleContainer .evergreen-link { } #_ctrl0_FooterPane_footer_pane_sec_ctl04_divModuleContainer .evergreen-link:not(:hover):not(:focus) { color: var(--evgLightColor); text-decoration-color: var(--evgLightColor); } #_ctrl0_FooterPane_footer_pane_sec_ctl04_divModuleContainer .evergreen-link:hover { color: var(--evgLightColor); text-decoration: none; text-decoration-color: var(--evgLightColor); } #_ctrl0_FooterPane_footer_pane_sec_ctl04_divModuleContainer .evergreen-link:focus, .evergreen-link:focus-visible { color: var(--evgLightColor); text-decoration-color: var(--evgLightColor); } Pipeline Pipeline opens in new window @media (max-width: 480px){ #_ctrl0_FooterPane_footer_pane_sec_ctl07_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { font-size: 20px; } #_ctrl0_FooterPane_footer_pane_sec_ctl07_divModuleContainer .evergreen-link { font-size: 14px; } } @media (min-width: 481px) and (max-width: 1024px){ #_ctrl0_FooterPane_footer_pane_sec_ctl07_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { font-size: 20px; } #_ctrl0_FooterPane_footer_pane_sec_ctl07_divModuleContainer .evergreen-link { font-size: 14px; } } @media (min-width: 1025px) { #_ctrl0_FooterPane_footer_pane_sec_ctl07_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { font-size: 20px; } #_ctrl0_FooterPane_footer_pane_sec_ctl07_divModuleContainer .evergreen-link { font-size: 14px; } } #_ctrl0_FooterPane_footer_pane_sec_ctl07_divModuleContainer.evergreen { background: var(--evgBrand1Color); } #_ctrl0_FooterPane_footer_pane_sec_ctl07_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { text-align: left; color: var(--evgLightColor); line-height: 1; } #_ctrl0_FooterPane_footer_pane_sec_ctl07_divModuleContainer .evergreen-item { background: var(--evgBrand1Color); border-bottom: 0 none; } #_ctrl0_FooterPane_footer_pane_sec_ctl07_divModuleContainer .evergreen-item-title { } #_ctrl0_FooterPane_footer_pane_sec_ctl07_divModuleContainer .evergreen-link { } #_ctrl0_FooterPane_footer_pane_sec_ctl07_divModuleContainer .evergreen-link:not(:hover):not(:focus) { color: var(--evgLightColor); text-decoration-color: var(--evgLightColor); } #_ctrl0_FooterPane_footer_pane_sec_ctl07_divModuleContainer .evergreen-link:hover { color: var(--evgLightColor); text-decoration-color: var(--evgLightColor); } #_ctrl0_FooterPane_footer_pane_sec_ctl07_divModuleContainer .evergreen-link:focus, .evergreen-link:focus-visible { color: var(--evgLightColor); text-decoration-color: var(--evgLightColor); } Investors Overview opens in new window News & Events opens in new window Stock Info opens in new window Financials opens in new window Governance opens in new window IR Resources opens in new window @media (max-width: 480px){ #_ctrl0_FooterPane_footer_pane_sec_ctl10_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { font-size: 20px; } #_ctrl0_FooterPane_footer_pane_sec_ctl10_divModuleContainer .evergreen-link { font-size: 14px; } } @media (min-width: 481px) and (max-width: 1024px){ #_ctrl0_FooterPane_footer_pane_sec_ctl10_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { font-size: 20px; } #_ctrl0_FooterPane_footer_pane_sec_ctl10_divModuleContainer .evergreen-link { font-size: 14px; } } @media (min-width: 1025px) { #_ctrl0_FooterPane_footer_pane_sec_ctl10_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { font-size: 20px; } #_ctrl0_FooterPane_footer_pane_sec_ctl10_divModuleContainer .evergreen-link { font-size: 14px; } } #_ctrl0_FooterPane_footer_pane_sec_ctl10_divModuleContainer.evergreen { background: var(--evgBrand1Color); } #_ctrl0_FooterPane_footer_pane_sec_ctl10_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { text-align: left; color: var(--evgLightColor); line-height: 1; } #_ctrl0_FooterPane_footer_pane_sec_ctl10_divModuleContainer .evergreen-item { background: var(--evgBrand1Color); border-bottom: 0 none; } #_ctrl0_FooterPane_footer_pane_sec_ctl10_divModuleContainer .evergreen-item-title { } #_ctrl0_FooterPane_footer_pane_sec_ctl10_divModuleContainer .evergreen-link { } #_ctrl0_FooterPane_footer_pane_sec_ctl10_divModuleContainer .evergreen-link:not(:hover):not(:focus) { color: var(--evgLightColor); text-decoration-color: var(--evgLightColor); } #_ctrl0_FooterPane_footer_pane_sec_ctl10_divModuleContainer .evergreen-link:hover { color: var(--evgLightColor); text-decoration-color: var(--evgLightColor); } #_ctrl0_FooterPane_footer_pane_sec_ctl10_divModuleContainer .evergreen-link:focus, .evergreen-link:focus-visible { color: var(--evgLightColor); text-decoration-color: var(--evgLightColor); } Careers Culture opens in new window Join Our Team opens in new window @media (max-width: 480px){ #_ctrl0_FooterPane_footer_pane_sec_ctl13_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { font-size: 20px; } #_ctrl0_FooterPane_footer_pane_sec_ctl13_divModuleContainer .evergreen-link { font-size: 14px; } } @media (min-width: 481px) and (max-width: 1024px){ #_ctrl0_FooterPane_footer_pane_sec_ctl13_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { font-size: 20px; } #_ctrl0_FooterPane_footer_pane_sec_ctl13_divModuleContainer .evergreen-link { font-size: 14px; } } @media (min-width: 1025px) { #_ctrl0_FooterPane_footer_pane_sec_ctl13_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { font-size: 20px; } #_ctrl0_FooterPane_footer_pane_sec_ctl13_divModuleContainer .evergreen-link { font-size: 14px; } } #_ctrl0_FooterPane_footer_pane_sec_ctl13_divModuleContainer.evergreen { background: var(--evgBrand1Color); } #_ctrl0_FooterPane_footer_pane_sec_ctl13_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { text-align: left; color: var(--evgLightColor); line-height: 1; } #_ctrl0_FooterPane_footer_pane_sec_ctl13_divModuleContainer .evergreen-item { background: var(--evgBrand1Color); border-bottom: 0 none; } #_ctrl0_FooterPane_footer_pane_sec_ctl13_divModuleContainer .evergreen-item-title { } #_ctrl0_FooterPane_footer_pane_sec_ctl13_divModuleContainer .evergreen-link { } #_ctrl0_FooterPane_footer_pane_sec_ctl13_divModuleContainer .evergreen-link:not(:hover):not(:focus) { color: var(--evgLightColor); text-decoration-color: var(--evgLightColor); } #_ctrl0_FooterPane_footer_pane_sec_ctl13_divModuleContainer .evergreen-link:hover { color: var(--evgLightColor); text-decoration-color: var(--evgLightColor); } #_ctrl0_FooterPane_footer_pane_sec_ctl13_divModuleContainer .evergreen-link:focus, .evergreen-link:focus-visible { color: var(--evgLightColor); text-decoration-color: var(--evgLightColor); } Contact Contact opens in new window #evergreen_grid_footer_pane_secondary.evergreen-grid .evergreen-grid-title { background-color: transparent; padding-top: 50px; padding-bottom: 0px; margin-bottom: -20px; } #evergreen_grid_footer_pane_secondary.evergreen-grid.evergreen-grid-wrapper { background-size: cover; background-position: center; background-repeat: no-repeat; position: relative; } #evergreen_grid_footer_pane_secondary.evergreen-grid.evergreen-grid-wrapper::after { position: absolute; content: ""; top: 0; left: 0; bottom: 0; right: 0; } #evergreen_grid_footer_pane_secondary.evergreen-grid .evergreen-grid-container { border-top: none ; border-bottom: none ; position: relative; z-index: 1; } #evergreen_grid_footer_pane_secondary.evergreen-grid .evergreen-grid-title, #evergreen_grid_footer_pane_secondary.evergreen-grid .evergreen-grid-module { z-index: 1; } #evergreen_grid_footer_pane_secondary.evergreen-grid { --evergreenGridModulePaddingLeft: 0; --evergreenGridModulePaddingRight: 0; } #evergreen_grid_footer_pane_secondary.evergreen-grid .evergreen-grid-module > .evergreen { padding-left: var(--evergreenGridModulePaddingLeft); padding-right: var(--evergreenGridModulePaddingRight); } #evergreen_grid_footer_pane_secondary.evergreen-grid .evergreen-grid.evergreen-grid-container { } @media (max-width: 480px){ #_ctrl0_FooterPane2_footer_pane_secondary_ctl04_divModuleContainer .evergreen-item-title { font-size: 10px; } #_ctrl0_FooterPane2_footer_pane_secondary_ctl04_divModuleContainer .evergreen-link { font-size: 12px; } } @media (min-width: 481px) and (max-width: 1024px){ #_ctrl0_FooterPane2_footer_pane_secondary_ctl04_divModuleContainer .evergreen-item-title { font-size: 10px; } #_ctrl0_FooterPane2_footer_pane_secondary_ctl04_divModuleContainer .evergreen-link { font-size: 12px; } } @media (min-width: 1025px) { #_ctrl0_FooterPane2_footer_pane_secondary_ctl04_divModuleContainer .evergreen-item-title { font-size: 10px; } #_ctrl0_FooterPane2_footer_pane_secondary_ctl04_divModuleContainer .evergreen-link { font-size: 12px; } } #_ctrl0_FooterPane2_footer_pane_secondary_ctl04_divModuleContainer.evergreen { background: var(--evgBrand1Color); } #_ctrl0_FooterPane2_footer_pane_secondary_ctl04_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { } #_ctrl0_FooterPane2_footer_pane_secondary_ctl04_divModuleContainer .evergreen-item { background: var(--evgBrand1Color); border-bottom: 0 none; } #_ctrl0_FooterPane2_footer_pane_secondary_ctl04_divModuleContainer .evergreen-item-title { } #_ctrl0_FooterPane2_footer_pane_secondary_ctl04_divModuleContainer .evergreen-link { text-transform: capitalize; } #_ctrl0_FooterPane2_footer_pane_secondary_ctl04_divModuleContainer .evergreen-link:not(:hover):not(:focus) { color: var(--evgBrand3Color); text-decoration-color: var(--evgBrand3Color); } #_ctrl0_FooterPane2_footer_pane_secondary_ctl04_divModuleContainer .evergreen-link:hover { color: var(--evgBrand3Color); text-decoration: underline solid; text-decoration-color: var(--evgBrand3Color); } #_ctrl0_FooterPane2_footer_pane_secondary_ctl04_divModuleContainer .evergreen-link:focus, .evergreen-link:focus-visible { color: var(--evgBrand3Color); text-decoration: underline solid; text-decoration-color: var(--evgBrand3Color); } Privacy Policy opens in new window | Terms of Use opens in new window | Site Map opens in new window #_ctrl0_FooterPane2_footer_pane_secondary_ctl07_divModuleContainer.evergreen-wysiwyg { background-color: var(--evgBrand1Color); } #_ctrl0_FooterPane2_footer_pane_secondary_ctl07_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { --alignment: center; } #_ctrl0_FooterPane2_footer_pane_secondary_ctl07_divModuleContainer .evergreen-item { --backgroundColor: var(--evgBrand1Color); } @media (min-width: 481px) and (max-width: 1024px) { #_ctrl0_FooterPane2_footer_pane_secondary_ctl07_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { } } @media (max-width: 480px) { #_ctrl0_FooterPane2_footer_pane_secondary_ctl07_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { } } #_ctrl0_FooterPane2_footer_pane_secondary_ctl07_divModuleContainer .evergreen-card-c { --border:none; } #_ctrl0_FooterPane2_footer_pane_secondary_ctl07_divModuleContainer .evergreen-card-c:hover { --border:none; } #_ctrl0_FooterPane2_footer_pane_secondary_ctl07_divModuleContainer .evergreen-card-c:focus { --border:none; } @media (max-width: 480px){ #_ctrl0_FooterPane2_footer_pane_secondary_ctl10_divModuleContainer .evergreen-item-title { font-size: 12px; } #_ctrl0_FooterPane2_footer_pane_secondary_ctl10_divModuleContainer .evergreen-link { font-size: 12px; } } @media (min-width: 481px) and (max-width: 1024px){ #_ctrl0_FooterPane2_footer_pane_secondary_ctl10_divModuleContainer .evergreen-item-title { font-size: 12px; } #_ctrl0_FooterPane2_footer_pane_secondary_ctl10_divModuleContainer .evergreen-link { font-size: 12px; } } @media (min-width: 1025px) { #_ctrl0_FooterPane2_footer_pane_secondary_ctl10_divModuleContainer .evergreen-item-title { font-size: 12px; } #_ctrl0_FooterPane2_footer_pane_secondary_ctl10_divModuleContainer .evergreen-link { font-size: 12px; } } #_ctrl0_FooterPane2_footer_pane_secondary_ctl10_divModuleContainer.evergreen { background: var(--evgBrand1Color); } #_ctrl0_FooterPane2_footer_pane_secondary_ctl10_divModuleContainer.evergreen .evergreen-credits .evergreen-container-content { display: flex; flex-direction: column; align-items: center; } #_ctrl0_FooterPane2_footer_pane_secondary_ctl10_divModuleContainer .evergreen-header .evergreen-title .ModuleTitle { line-height: 1; } #_ctrl0_FooterPane2_footer_pane_secondary_ctl10_divModuleContainer .evergreen-credit-item.evergreen-item { display: flex; flex-direction: row; align-items: center; padding-top: 1px; padding-bottom: 2px; } #_ctrl0_FooterPane2_footer_pane_secondary_ctl10_divModuleContainer .evergreen-item { background: var(--evgBrand1Color); border-bottom: 0 none; } #_ctrl0_FooterPane2_footer_pane_secondary_ctl10_divModuleContainer .evergreen-item-title { text-transform: none; line-height: 1; } #_ctrl0_FooterPane2_footer_pane_secondary_ctl10_divModuleContainer .evergreen-item-title:not(:hover):not(:focus) { color: var(--evgBrand3Color); } #_ctrl0_FooterPane2_footer_pane_secondary_ctl10_divModuleContainer .evergreen-item-title:hover { color: var(--evgBrand3Color); } #_ctrl0_FooterPane2_footer_pane_secondary_ctl10_divModuleContainer .evergreen-item-title:focus { color: var(--evgBrand3Color); } #_ctrl0_FooterPane2_footer_pane_secondary_ctl10_divModuleContainer .evergreen-link { text-transform: none; color: var(--evgBrand3Color); color: var(--evgBrand3Color); color: var(--evgBrand3Color); font-weight: normal; line-height: 1; } #_ctrl0_FooterPane2_footer_pane_secondary_ctl10_divModuleContainer .evergreen-link:not(:hover):not(:focus) { text-decoration: none; text-decoration-color: var(--evgBrand3Color); } #_ctrl0_FooterPane2_footer_pane_secondary_ctl10_divModuleContainer .evergreen-link:hover { text-decoration-color: var(--evgBrand3Color); } #_ctrl0_FooterPane2_footer_pane_secondary_ctl10_divModuleContainer .evergreen-link:focus { text-decoration-color: var(--evgBrand3Color); } © 2026 Shattuck Labs, Inc. - All rights reserved Powered By Q4 Inc. 5.187.1.9 (opens in new window) q4EvergreenHelpers.stickyNavBar({ layoutSelector: ".evergreen-layout", headerSelector: '.evergreen-section--navigation', navSelector: '.evergreen-pane--navigation', navContainerSelector: '.evergreen-section--navigation', }); //<![CDATA[ var Page_Validators = new Array(document.getElementById("_ctrl0_FooterPane_footer_pane_main_ctl10_reqEmailAddress"), document.getElementById("_ctrl0_FooterPane_footer_pane_main_ctl10_ctl04"), document.getElementById("_ctrl0_FooterPane_footer_pane_main_ctl10_cusvalMailingListsValidator"), document.getElementById("_ctrl0_FooterPane_footer_pane_main_ctl10_cusvalRecaptcha")); //]]> //<![CDATA[ var _ctrl0_FooterPane_footer_pane_main_ctl10_reqEmailAddress = document.all ? document.all["_ctrl0_FooterPane_footer_pane_main_ctl10_reqEmailAddress"] : document.getElementById("_ctrl0_FooterPane_footer_pane_main_ctl10_reqEmailAddress"); _ctrl0_FooterPane_footer_pane_main_ctl10_reqEmailAddress.controltovalidate = "_ctrl0_FooterPane_footer_pane_main_ctl10_txtEmailAddress"; _ctrl0_FooterPane_footer_pane_main_ctl10_reqEmailAddress.errormessage = "Email Address is required."; _ctrl0_FooterPane_footer_pane_main_ctl10_reqEmailAddress.validationGroup = "989e2049-79ca-468c-aa11-352373fa8127"; _ctrl0_FooterPane_footer_pane_main_ctl10_reqEmailAddress.evaluationfunction = "RequiredFieldValidatorEvaluateIsValid"; _ctrl0_FooterPane_footer_pane_main_ctl10_reqEmailAddress.initialvalue = ""; var _ctrl0_FooterPane_footer_pane_main_ctl10_ctl04 = document.all ? document.all["_ctrl0_FooterPane_footer_pane_main_ctl10_ctl04"] : document.getElementById("_ctrl0_FooterPane_footer_pane_main_ctl10_ctl04"); _ctrl0_FooterPane_footer_pane_main_ctl10_ctl04.controltovalidate = "_ctrl0_FooterPane_footer_pane_main_ctl10_txtEmailAddress"; _ctrl0_FooterPane_footer_pane_main_ctl10_ctl04.errormessage = "Email Address is invalid."; _ctrl0_FooterPane_footer_pane_main_ctl10_ctl04.validationGroup = "989e2049-79ca-468c-aa11-352373fa8127"; var _ctrl0_FooterPane_footer_pane_main_ctl10_cusvalMailingListsValidator = document.all ? document.all["_ctrl0_FooterPane_footer_pane_main_ctl10_cusvalMailingListsValidator"] : document.getElementById("_ctrl0_FooterPane_footer_pane_main_ctl10_cusvalMailingListsValidator"); _ctrl0_FooterPane_footer_pane_main_ctl10_cusvalMailingListsValidator.errormessage = "Investor Alert Options is required."; _ctrl0_FooterPane_footer_pane_main_ctl10_cusvalMailingListsValidator.validationGroup = "989e2049-79ca-468c-aa11-352373fa8127"; _ctrl0_FooterPane_footer_pane_main_ctl10_cusvalMailingListsValidator.evaluationfunction = "CustomValidatorEvaluateIsValid"; var _ctrl0_FooterPane_footer_pane_main_ctl10_cusvalRecaptcha = document.all ? document.all["_ctrl0_FooterPane_footer_pane_main_ctl10_cusvalRecaptcha"] : document.getElementById("_ctrl0_FooterPane_footer_pane_main_ctl10_cusvalRecaptcha"); _ctrl0_FooterPane_footer_pane_main_ctl10_cusvalRecaptcha.errormessage = "The captcha test has failed. Please try again."; _ctrl0_FooterPane_footer_pane_main_ctl10_cusvalRecaptcha.validationGroup = "989e2049-79ca-468c-aa11-352373fa8127"; _ctrl0_FooterPane_footer_pane_main_ctl10_cusvalRecaptcha.evaluationfunction = "CustomValidatorEvaluateIsValid"; //]]> //<![CDATA[ var Page_ValidationActive = false; if (typeof(ValidatorOnLoad) == "function") { ValidatorOnLoad(); } function ValidatorOnSubmit() { if (Page_ValidationActive) { return ValidatorCommonOnSubmit(); } else { return true; } } theForm.oldSubmit = theForm.submit; theForm.submit = WebForm_SaveScrollPositionSubmit; theForm.oldOnSubmit = theForm.onsubmit; theForm.onsubmit = WebForm_SaveScrollPositionOnSubmit; //]]> (function () { const iframe = document.getElementById("q4l-idp-iframe"); iframe.onload = function () { const redirectUrl = iframe.contentWindow.location.href; if (redirectUrl !== iframe.src) { iframe.src = redirectUrl; } } })(); Q4IdpLogin.IframeRedirectURI = "https://identity.q4inc.com/oauth/auth?response_type=code&client_id=q4-studio-public-client&redirect_uri=https%3A%2F%2Fauth.platform.q4inc.com%2Fauth%2Fv2%2FpublicAuthRedirect&scope=openid%20profile%20email&state=eyJhbGciOiJodHRwOi8vd3d3LnczLm9yZy8yMDAxLzA0L3htbGRzaWctbW9yZSNobWFjLXNoYTI1NiIsInR5cCI6IkpXVCJ9.eyJyZXR1cm5VcmwiOiJodHRwczovL2lyLnNoYXR0dWNrbGFicy5jb20vUTRJZHBMb2dpbkNhbGxiYWNrLmFzcHgiLCJleHAiOjE3OTcxOTQ2MzYuMCwiaWF0IjoxNzg5NDE4NjM2LjAsImlzcyI6IlE0LldlYi5QdWJsaWMuU2l0ZSIsImF1ZCI6InVwc3RyZWFtLmNkbi53ZWIucHJkLnE0aW5jLmNvbSJ9.TmgcCHR4DoMZoLb_fBNu_nZow1tquj9BhB2FyJLkMlo&prompt=none"; document.addEventListener('DOMContentLoaded', function () { var evgElement = document.getElementsByClassName("evergreen-layout"); if (evgElement.length == 0) { var skipLink = document.getElementById("skip-link"); if (skipLink) { skipLink.remove(); } } });

The release as fetched from its publisher. shattucklabs.com ↗